APA (7th ed.) Citation

M, C., VE, D., A, C., C, L., C, S., RPA, v. E., . . . J, S. (2026). Safety and Efficacy of PrimeC in Amyotrophic Lateral Sclerosis: The PARADIGM Randomized Clinical Trial. JAMA neurology, 83(5), 471. https://doi.org/10.1001/jamaneurol.2026.0230

Chicago Style (17th ed.) Citation

M, Cudkowicz, et al. "Safety and Efficacy of PrimeC in Amyotrophic Lateral Sclerosis: The PARADIGM Randomized Clinical Trial." JAMA Neurology 83, no. 5 (2026): 471. https://doi.org/10.1001/jamaneurol.2026.0230.

MLA (9th ed.) Citation

M, Cudkowicz, et al. "Safety and Efficacy of PrimeC in Amyotrophic Lateral Sclerosis: The PARADIGM Randomized Clinical Trial." JAMA Neurology, vol. 83, no. 5, 2026, p. 471, https://doi.org/10.1001/jamaneurol.2026.0230.